Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Small Molecules in Stem Cell Research.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Tysabri screening test may be unreliable
How to treat tumefactive demyelinating disease?
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Regulatory effects of fisetin on microglial activation.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
The nervous system's potential role in multiple sclerosis associated bone loss.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
[Marihuana and cannobinoids as medicaments].
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.

Pages